Innovation Pharmaceuticals Inc (IPIX)

[ROMAD Diver]

I was re-reading the NT 10-Q, and I feel the 10-Q has a high probability to be underwhelming for most here.

Correct me if I’m wrong, but something like a delay caused by Leo being busy satisfying regulatory requirements in order to just start the trials could be cause for this justification:


“Innovation Pharmaceuticals Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q (the “Quarterly Report”) for the period ended December 31, 2020 (the “Reporting Period”) by the February 16, 2021 filing due date applicable to non-accelerated filers due to a delay experienced by the Registrant in preparing disclosure relating to recent developments regarding clinical trials for the Registrant’s lead drug compound, and in particular, developments on or around the filing due date relating to clinical trials in the United States and Russia. The Registrant anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed filing due date.“


The “developments” could be simply referring to the start of the trial and nothing more. I think this is a lot more likely than some of the other theories I’ve seen on the web the past 24 hours.